The Food and Drug Administration has approved home use of a device that helps people with spinal cord injuries regain mobility and functioning. Onward Medical announced Monday that the company had received 510(k) clearance to expand the use of their spinal cord stimulator outside of clinics.

“People living with [spinal cord injuries] will now be able to benefit from use of the ARC-EX System in the comfort and convenience of their own homes,” said CEO Dave Marver in a press release.

FDA first approved clinical use of the device in 2024, after designating it a Breakthrough Device . An earlier trial demonstrated that small zaps delivered on the skin and along the spine boosted hand and arm function in 72% of participants when paired with rehabilitative therapy. No serious adverse outcom

See Full Page